Stay updated on DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial

Sign up to get notified when there's something new on the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T18:04:28.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T15:43:12.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new phase II clinical trial for high-grade B-cell lymphoma, including changes to the trial design and eligibility criteria. Key details about the trial's structure and the investigational treatments have been added, while some previous content regarding prognosis and treatment comparisons has been removed.
    Difference
    50%
    Check dated 2025-04-16T12:46:44.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:34:07.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:38:41.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T13:27:09.000Z thumbnail image

Stay in the know with updates to DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page.